Assenagon Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
+62,334
New +$1.75M ﹤0.01% 872
2025
Q3
Sell
-47,002
Closed -$1.54M 1175
2025
Q2
$1.54M Sell
47,002
-99,094
-68% -$3.22M ﹤0.01% 836
2025
Q1
$4.71M Buy
146,096
+6,995
+5% +$260K 0.01% 547
2024
Q4
$4.25M Sell
139,101
-90,029
-39% -$2.9M 0.01% 733
2024
Q3
$6.42M Buy
229,130
+138,046
+152% +$3.4M 0.01% 649
2024
Q2
$2.07M Sell
91,084
-353,717
-80% -$8.16M ﹤0.01% 877
2024
Q1
$13.5M Buy
444,801
+185,632
+72% +$6.22M 0.03% 358
2023
Q4
$9.25M Buy
259,169
+56,761
+28% +$2.11M 0.02% 472
2023
Q3
$8.87M Sell
202,408
-208,929
-51% -$10.2M 0.03% 411
2023
Q2
$20.3M Buy
411,337
+183,824
+81% +$8.47M 0.07% 230
2023
Q1
$9.43M Buy
+227,513
New +$9.44M 0.03% 399
2021
Q4
Sell
-147,245
Closed -$10.2M 1424
2021
Q3
$10.2M Buy
+147,245
New +$11.3M 0.03% 287
2021
Q1
Sell
-30,497
Closed -$1.7M 1192
2020
Q4
$1.7M Buy
+30,497
New +$1.32M 0.01% 569
2019
Q3
Sell
-80,848
Closed -$2.41M 841
2019
Q2
$2.41M Sell
80,848
-143,334
-64% -$4.18M 0.02% 472
2019
Q1
$6.01M Buy
224,182
+185,761
+483% +$5.64M 0.06% 275
2018
Q4
$1.18M Sell
38,421
-27,579
-42% -$859K 0.01% 601
2018
Q3
$2.31M Buy
+66,000
New +$2.09M 0.02% 488

Other funds holding ATRC

Assenagon Asset Management's ATRC Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in AtriCure (ATRC) in Q2 2026: 62,334 shares worth $1.74M. The stake represents ﹤0.01% of the portfolio and ranks #872 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in ATRC as recently as Q2 2025.

Assenagon Asset Management first reported a position in ATRC in Q3 2018 and has held it in 17 quarters since. The position peaked at $20.3M in Q2 2023. 15 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Assenagon Asset Management held 62,334 shares of AtriCure worth $1.74M as of Q2 2026.
  • AtriCure was a new Assenagon Asset Management position in Q2 2026.
  • AtriCure made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #872 holding.
  • Assenagon Asset Management first reported a position in AtriCure in Q3 2018 and has held it in 17 quarters since.
  • Assenagon Asset Management's AtriCure position peaked at $20.3M in Q2 2023.
  • 15 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.